Virtual Dialogue 2 Registration

Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 2

Innovations in Diagnosing and Treating Chondrosarcoma
Second International Virtual Dialogue (VIA Zoom)
Saturday, March 20, 2021
1:00PM – 2:30PM (Eastern Standard Time / New York)

The Chondrosarcoma CS Foundation, Inc. will host its second International Forum / Virtual Dialogue featuring two prominent experts to examine two critical topics:


Using Medication to Treat Chondrosarcoma

Jonathan C. Trent, M.D. Associate Director Clinical Research, Director Bone and Soft-tissue Sarcoma Group, Sylvester Comprehensive Cancer Center in Miami, Fl.

Jonathan Trent will review the clinical trials he conducted using Ivosidenib (Tibsovo) a medication used to inhibit the IDH 1 biomarker in Chondrosarcoma and the role medications like Ivosidenib will have in treating Chondrosarcoma.


Improving the Standard of Care for Chondrosarcoma: Update on Research and Diagnostic Screening Techniques.

Professor Adrienne M Flanagan MB PhD, Academic Head of Pathology UCL; London, England.

Adrienne Flanagan, will discuss her research on the molecular classification for primary bone tumours resulting in the introduction of diagnostic markers, for chondrosarcoma, which are now used globally as well as improvements to detect these biomarkers.


To Register for the event fill out the registration form below.